Eszter Banki

Pecs, BA 7624, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Protective Effects of PACAP in a Rat Model of Diabetic Neuropathy.

Protective Effects of PACAP in a Rat Model of Diabetic Neuropathy.

Journal: International journal of molecular sciences

Published: August 31, 2021

Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.

Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.

Journal: Neuroscience

Published: April 07, 2015

Caloric restriction confers persistent anti-oxidative, pro-angiogenic, and anti-inflammatory effects and promotes anti-aging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats.

Caloric restriction confers persistent anti-oxidative, pro-angiogenic, and anti-inflammatory effects and promotes anti-aging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats.

Journal: American journal of physiology. Heart and circulatory physiology

Published: June 08, 2014

Age-related decline of autocrine pituitary adenylate cyclase-activating polypeptide impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.

Age-related decline of autocrine pituitary adenylate cyclase-activating polypeptide impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.

Journal: The journals of gerontology. Series A, Biological sciences and medical sciences

Published: May 07, 2014

The selective PAC1 receptor agonist maxadilan inhibits neurogenic vasodilation and edema formation in the mouse skin.

The selective PAC1 receptor agonist maxadilan inhibits neurogenic vasodilation and edema formation in the mouse skin.

Journal: Neuropharmacology

Published: April 16, 2014

Characterization of the thermoregulatory response to pituitary adenylate cyclase-activating polypeptide in rodents.

Characterization of the thermoregulatory response to pituitary adenylate cyclase-activating polypeptide in rodents.

Journal: Journal of molecular neuroscience : MN

Published: April 15, 2014

Molecular mechanisms underlying the Nephroprotective effects of PACAP in diabetes.

Molecular mechanisms underlying the Nephroprotective effects of PACAP in diabetes.

Journal: Journal of molecular neuroscience : MN

Published: November 15, 2013

Examination of PACAP38-like immunoreactivity in different milk and infant formula samples.

Examination of PACAP38-like immunoreactivity in different milk and infant formula samples.

Journal: Acta physiologica Hungarica

Published: March 09, 2013

Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy.

Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy.

Journal: Peptides

Published: January 02, 2013

PACAP immunoreactivity in human malignant tumor samples and cardiac diseases.

PACAP immunoreactivity in human malignant tumor samples and cardiac diseases.

Journal: Journal of molecular neuroscience : MN

Published: March 30, 2012

Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation.

Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation.

Journal: Journal of molecular neuroscience : MN

Published: March 14, 2012

Protective effects of the neuropeptide PACAP in diabetic retinopathy.

Protective effects of the neuropeptide PACAP in diabetic retinopathy.

Journal: Cell and tissue research

Published: November 22, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026